1. Bayliss M, Rendas-Baum R, White MK, et al. Health-related quality of life (HRQL) for individuals with self-reported chronic physical and/or mental health conditions: panel survey of an adult sample in the United States. Health Qual Life Outcomes 2012;10:154.

2. Asnani MR, Fraser R, Lewis NA, Reid ME. Depression and loneliness in Jamaicans with sickle cell disease. BMC Psychiatry 2010;10:40.

3. Benton TD, Ifeagwu JA, Smith-Whitley K. Anxiety and depression in children and adolescents with sickle cell disease. Curr Psychiatry Rep 2007;9:114–21.

4. Hasan SP, Hashmi S, Alhassen M, et al. Depression in sickle cell disease. J Natl Med Assoc 2003;95:533–7.

5. Hilton C, Osborn M, Knight S, et al. Psychiatric complications of homozygous sickle cell disease among young adults in the Jamaican Cohort Study. Br J Psychiatry 1997;170:69–76.

6. Jerrell JM, Tripathi A, McIntyre RS. Prevalence and treatment of depression in children and adolescents with sickle cell disease: a retrospective cohort study. Prim Care Companion CNS Disord 2011;13(2).

7. Udofia O, Oseikhuemen AE. Psychiatric morbidity in patients with sickle cell anaemia. West Afr J Med 1996;15:196–200.

8. Wilson Schaeffer JJ, Gil KM, Burchinal M, et al. Depression, disease severity, and sickle cell disease. J Behav Med 1999;22:115–26.

9. Ballas S, Kessen MR, Goldberg MF, et al. Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. Sci World J 2012;2012.

10. Levenson JL, McClish DK, Dahman BA, et al. Depression and anxiety in adults with sickle cell disease: the PiSCES project. Psychosom Med 2008;70:192–6.

11. Thomas VJ, Hambleton I, Serjeant G. Psychological distress and coping in sickle cell disease: comparison of British and Jamaican attitudes. Ethn Health 2001;6:129–36.

12. Jenerette C, Funk M, Murdaugh C. Sickle cell disease: a stigmatizing condition that may lead to depression. Issues Ment Health Nurs 2005;26:1081–101.

13. Gil KM, Carson JW, Porter LS, et al. Daily mood and stress predict pain, health care use, and work activity in African American adults with sickle-cell disease. Health Psychol 2004;23:267–74.

14. Ware JE, Kosinski M. SF-36 physical and mental health summary scales: A manual for users of version 1. 2nd ed. Lincoln, RI: QualityMetric; 2001.

15. Aisiku IP, Smith WR, McClish DK, et al. Comparisons of high versus low emergency department utilizers in sickle cell disease. Ann Emerg Med 2009;53:587–93.

16. Dampier C, LeBeau P, Rhee S, et al. Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium. Am J Hematol 2011;86:203–5.

17. Anie KA, Grocott H, White L, et al. Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease. BMJ Open 2012;2(4).

18. Anie KA, Steptoe A, Bevan DH. Sickle cell disease: Pain, coping and quality of life in a study of adults in the UK. Br J Health Psychol 2002;7(Part 3):331–44.

19. Treadwell MJ, Hassell K, Levine R, Keller S. Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me): Conceptual model based on review of the literature and formative research. Clin J Pain 2014;30:902–14.

20. Edwards CL, Scales MT, Loughlin C, et al. A brief review of the pathophysiology, associated pain, and psychosocial issues in sickle cell disease. Int J Behav Med 2005;12:171–9.

21. Jenerette CM, Brewer C. Health-related stigma in young adults with sickle cell disease. J Natl Med Assoc 2010;102:1050–5.

22. Jenerette CM, Lauderdale G. Successful aging with sickle cell disease: using qualitative methods to inform theory. J Theory Constr Test 2008;12:16-24.

23. Price JH, Khubchandani J, McKinney M, Braun R. Racial/ethnic disparities in chronic diseases of youths and access to health care in the United States. Biomed Res Int 2013;2013:787616.

24. Brousseau DC, Owens PL, Mosso AL, et al. Acute care utilization and rehospitalizations for sickle cell disease. JAMA 2010;303:1288–94.

25. Brandow AM, Panepinto JA. Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities. Expert Rev Hematol 2010;3:255–60.

26. Haywood C, Jr., Beach MC, Lanzkron S, et al. A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease. J Natl Med Assoc 2009;101:1022–33.

27. Haywood C, Jr., Lanzkron S, Ratanawongsa N, et al. The association of provider communication with trust among adults with sickle cell disease. J Gen Intern Med 2010;25:543–8.

28. Tanabe P, Artz N, Mark Courtney D, et al. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management. Acad Emerg Med 2010;17:399–407.

29. Crosby LE, Modi AC, Lemanek KL, et al. Perceived barriers to clinic appointments for adolescents with sickle cell disease. J Pediatr Hematol Oncol 2009;31:571–6.

30. Fedele DA, Molzon ES, Eddington AR, et al. Perceived barriers to care in a pediatric medical home: the moderating role of caregiver minority status. Clin Pediatr (Phila) 2014;53:351–5.

31. Seid M, Sobo EJ, Gelhard LR, Varni JW. Parents’ reports of barriers to care for children with special health care needs: development and validation of the barriers to care questionnaire. Ambul Pediatr 2004;4:323-31.

32. Oyeku SO, Wang CJ, Scoville R, et al. Hemoglobinopathy Learning Collaborative: using quality improvement (QI) to achieve equity in health care quality, coordination, and outcomes for sickle cell disease. J Health Care Poor Underserved 2012;23(3 Suppl):34–48.

33. Rehabilitation Research & Training Center: Health & Wellness Consortium. Summary of studies and key findings. Portland, OR: Oregon Health & Science University; 2003.

34. Treadwell M, Barreda F, Major K, et al. Mental health symptoms, quality of life and barriers to accessing health care in sickle cell disease. Blood 2011;118:337.

35. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatric Ann 2002;32:509–21.

36. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Assocaition; 2000.

37. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13.

38. Bauer AM, Chan YF, Huang H, et al. Characteristics, management, and depression outcomes of primary care patients who endorse thoughts of death or suicide on the PHQ-9. J Gen Intern Med 2013;28:363–9.

39. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092–7.

40. Swinson RP. The GAD-7 scale was accurate for diagnosing generalised anxiety disorder. Evid Based Med 2006;11:184.

41. Kroenke K, Spitzer RL, Williams JB, et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007;146:317–25.

42. Panepinto JA, Pajewski NM, Foerster LM, et al. Impact of family income and sickle cell disease on the health-related quality of life of children. Qual Life Res 2009;18:5–13.

43. Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 2003;3:329–41.

44. Ballas SK, Barton FB, Waclawiw MA, et al. Hydroxyurea and sickle cell anemia: effect on quality of life. Health Qual Life Outcomes 2006;4:59.

45. McClish DK, Penberthy LT, Bovbjerg VE, et al. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes 2005;3:50.

46. McClish DK, Levenson JL, Penberthy LT, et al. Gender differences in pain and healthcare utilization for adult sickle cell patients: The PiSCES Project. J Womens Health (Larchmt) 2006;15:146–54.

47. Stata statistical software: release 13. College Station, TX: StataCorp LP; 2013.

48. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317–22.

49. Robinson MR, Daniel LC, O’Hara EA, et al. Insurance status as a sociodemographic risk factor for functional outcomes and health-related quality of life among youth with sickle cell disease. J Pediatr Hematol Oncol 2014;36:51–6.

50. Cohen JS, Biesecker BB. Quality of life in rare genetic conditions: a systematic review of the literature. Am J Med Genet A 2010;152A:1136–56.

51. Brawley OW, Cornelius LJ, Edwards LR, et al. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. Ann Intern Med 2008;148:932–8.

52. Glanz K, Rimer B, Viswanath K. Health behavior and health education. 4th ed. San Francisco, CA: Wiley; 2008.

53. McLaren L, Hawe P. Ecological perspectives in health research. J Epidemiol Community Health 2005;59:6–14.

54. Lawrence R, Gootman J, Sim E. Adolescent health services: Missing opportunities. Washington, DC: National Academies Press; 2009.

55. Thota AB, Sipe TA, Byard GJ, et al. Collaborative care to improve the management of depressive disorders: a community guide systematic review and meta-analysis. Am J Prev Med 2012;42:525–38.

56. Miranda J, Duan N, Sherbourne C, et al. Improving care for minorities: can quality improvement interventions improve care and outcomes for depressed minorities? Results of a randomized, controlled trial. Health Serv Res 2003;38:613–30.

57. Miranda J, Schoenbaum M, Sherbourne C, et al. Effects of primary care depression treatment on minority patients’ clinical status and employment. Arch Gen Psychiatry 2004;61:827–34.

58. Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care 2007;45(5 Suppl 1):S3–S11.

59. Collins PY, Insel TR, Chockalingam A, et al. Grand challenges in global mental health: integration in research, policy, and practice. PLoS Med 2013;10(4):e1001434.

60. Riley WT, Pilkonis P, Cella D. Application of the National Institutes of Health Patient-reported Outcome Measurement Information System (PROMIS) to mental health research. J Ment Health Policy Econ 2011;14:201–8.

61. Haynes SN, O’Brian WH. Principals and practices of behavioral assessment. New York: Kluwer Academic/Plenum; 2000.

62. Sawyer MG, Whaites L, Rey JM, et al. Health-related quality of life of children and adolescents with mental disorders. J Am Acad Child Adolesc Psychiatry 2002;41:530–7.

63. Lin EH, Katon W, Von Korff M, et al. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA 2003;290:2428–9.

64. Sawyer MG, Arney FM, Baghurst PA, et al. The mental health of young people in Australia: key findings from the child and adolescent component of the national survey of mental health and well-being. Aust N Z J Psychiatry 2001;35:806–14.

65. Thornburg CD, Calatroni A, Panepinto JA. Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea. J Pediatr Hematol Oncol 2011;33:251–4.

66. Keller S, Yang M, Treadwell MJ, et al. Patient reports of health outcome for adults living with sickle cell disease: development and testing of ASCQ-Me item banks. Health Qual Life Outcomes 2014;12:125.

Kimpreet Kaur, BS

Article

Emotional Distress, Barriers to Care, and Health-Related Quality of Life in Sickle Cell Disease